Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 513

1.

Risk factors in liver retransplantation: a single-center experience.

Crivellin C, De Martin E, Germani G, Gambato M, Senzolo M, Russo FP, Vitale A, Zanus G, Cillo U, Burra P.

Transplant Proc. 2011 May;43(4):1110-3. doi: 10.1016/j.transproceed.2011.01.141.

PMID:
21620065
2.

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.

Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW.

Ann Surg. 1999 Jun;229(6):824-31; discussion 831-3.

3.

Liver retransplantation in adults: a 20-year experience of one center in southern Brazil.

Costabeber AM, Granzotto M, Fleck Ade M Jr, Marroni CA, Zanotelli ML, Cantisani G, Lionço L, Musskopf MI, Brandão A; Liver Transplantation Group.

Ann Hepatol. 2013 Nov-Dec;12(6):942-51.

4.

A single-center experience of retransplantation for liver transplant recipients with a failing graft.

Chen GH, Fu BS, Cai CJ, Lu MQ, Yang Y, Yi SH, Xu C, Li H, Wang GS, Zhang T.

Transplant Proc. 2008 Jun;40(5):1485-7. doi: 10.1016/j.transproceed.2008.01.076.

PMID:
18589134
5.

Morbidity and mortality in liver retransplantation.

Alamo JM, Gómez MA, Pareja F, Martínez A, López F, Romero E, Barrera L, Serrano J, García I, Bernardos A.

Transplant Proc. 2006 Oct;38(8):2475-7.

PMID:
17097972
6.

Retransplantation for late liver graft failure: predictors of mortality.

Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, Guy SR, Fishbein TM, Schwartz ME, Sheiner PA.

Liver Transpl. 2000 Mar;6(2):174-9.

PMID:
10719016
7.

Graft loss following liver transplantation in patients with chronic hepatitis C.

Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P.

Transplantation. 1996 Dec 27;62(12):1773-6.

PMID:
8990361
8.

Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.

Baccarani U, Adani GL, Bragantini F, Londero A, Comuzzi C, Rossetto A, Lorenzin D, Bresadola V, Risaliti A, Pea F, Toniutto P, Donini A, De Anna D, Bresadola F, Tavio M, Viale P.

Transplant Proc. 2011 May;43(4):1119-22. doi: 10.1016/j.transproceed.2011.01.124.

PMID:
21620067
9.

Late hepatic artery thrombosis after orthotopic liver transplantation.

Gunsar F, Rolando N, Pastacaldi S, Patch D, Raimondo ML, Davidson B, Rolles K, Burroughs AK.

Liver Transpl. 2003 Jun;9(6):605-11.

10.

[Diagnosis and treatment of hepatic artery thrombosis after liver transplantation].

Proposito D, Loinaz Segurola C, Garcìa Garcìa I, Jimènez C, Gonzà lez Pinto I, Gòmez Sanz R, Urruzuno P, Medina E, Moreno Gonzàlez E.

Chir Ital. 2000 Sep-Oct;52(5):505-25. Italian.

PMID:
11190544
11.

Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.

Biselli M, Gramenzi A, Del Gaudio M, Ravaioli M, Vitale G, Gitto S, Grazi GL, Pinna AD, Andreone P, Bernardi M; Bologna Liver Transplantation Group.

J Clin Gastroenterol. 2010 Jan;44(1):52-7. doi: 10.1097/MCG.0b013e3181a390a8.

PMID:
19581813
12.

Influence of selected factors on survival after liver retransplantation.

Remiszewski P, Kalinowski P, Dudek K, Grodzicki M, Paluszkiewicz R, Zieniewicz K, Krawczyk M.

Transplant Proc. 2011 Oct;43(8):3025-8. doi: 10.1016/j.transproceed.2011.08.026.

PMID:
21996216
13.

Post-hepatitis primary disease does not influence 6-year survival after liver transplantation beyond 1 year.

Caccamo L, Colledan M, Rossi G, Gridelli B, Maggi U, Vannelli A, Damilano I, Lucianetti A, Paone G, Gatti S, Reggiani P, Fassati LR.

Transpl Int. 1998;11 Suppl 1:S212-20.

PMID:
9664982
14.

Retransplantation for recurrent hepatitis C.

Sheiner PA, Schluger LK, Emre S, Thung SN, Lau JY, Guy SR, Schwartz ME, Miller CM.

Liver Transpl Surg. 1997 Mar;3(2):130-6.

15.

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.

Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA Jr, Lobue A, Zurstrassen MP, Moraes JM Jr, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.

Transplant Proc. 2007 Oct;39(8):2511-3.

PMID:
17954160
16.

[Assessment of risk factors in the incidence of hepatic artery thrombosis in a consecutive series of 687 liver transplantations].

Proposito D, Loinaz Segurola C, Garcia Garcìa I, Jimènez C, Gonzalez Pinto I, Gomez Sanz R, De La Cruz J, Moreno Gonzàlez E.

Ann Ital Chir. 2001 Mar-Apr;72(2):187-205. Review. Italian.

PMID:
11552475
17.

Arterial conduits for hepatic artery revascularisation in adult liver transplantation.

Muralidharan V, Imber C, Leelaudomlipi S, Gunson BK, Buckels JA, Mirza DF, Mayer AD, Bramhall SR.

Transpl Int. 2004 May;17(4):163-8. Epub 2004 Apr 24.

18.

Poor survival after liver retransplantation: is hepatitis C to blame?

Watt KD, Lyden ER, McCashland TM.

Liver Transpl. 2003 Oct;9(10):1019-24.

19.

Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.

Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Cescon M, Varotti G, Ramacciato G, Vetrone G, Zanello M, Pinna AD.

Liver Transpl. 2006 Jul;12(7):1104-11.

20.

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.

Am J Gastroenterol. 1997 Sep;92(9):1453-7.

PMID:
9317061

Supplemental Content

Support Center